Sinouvassane Djearamane

Dr. Sinouvassane Djearamane


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
NNNaurah Nabihah Nasir
Naurah Nabihah Nasir
Mahendran SekarMahendran Sekar
Mahendran Sekar
SRSubban Ravi
Subban Ravi
LWLing Shing Wong
Ling Shing Wong
SSSreenivas Patro Sisinthy
Sreenivas Patro Sisinthy
SDSinouvassane Djearamane
Sinouvassane Djearamane
Streptonigrin is an aminoquinone alkaloid isolated from Streptomyces flocculus and is gaining attention as a drug molecule owing to its potential antitumor and antibiotic effects. It was previously used as an anticancer drug but has been discontinued because of its toxic effects. However, according to the most recent studies, the toxicity of streptonigrin and its structurally modified derivatives has been reduced while maintaining their potential pharmacological action at lower concentrations. To date, many investigations have been conducted on this molecule and its derivatives to determine the most effective molecule with low toxicity to enable new drug discovery. Therefore, the main objective of this study is to provide a comprehensive review and to discuss the prospects for streptonigrin and its derived compounds, which may boost the molecule as a highly interesting target molecule for new drug design, development and therapy. To complete this review, relevant literature was collected from several scientific databases, including Google Scholar, PubMed, Scopus and ScienceDirect. Following a complete screening, the obtained information is summarized in the present review to provide a good reference and accelerate the development and utilization of streptonigrin and its derivatives as pharmaceuticals. Graphical Abstract:

1 April 2023 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
MYMuhamad Azrul Amir Yusri
Muhamad Azrul Amir Yusri
Mahendran SekarMahendran Sekar
Mahendran Sekar
LWLing Shing Wong
Ling Shing Wong
MIMd Asiful Islam
Md Asiful Islam
SRSubban Ravi
Subban Ravi
SDSinouvassane Djearamane
Sinouvassane Djearamane
Celastrol is a naturally occurring chemical isolated from Tripterygium wilfordii Hook. f., root extracts widely known for their neuroprotective properties. In this review, we focus on the efficacy of celastrol in mitigating memory impairment (MI) in both in vivo and in vitro models. Scopus, PubMed and Web of Science databases were utilised to locate pertinent literatures that explore the effects of celastrol in the brain, including its pharmacokinetics, bioavailability, behavioral effects and some of the putative mechanisms of action on memory in many MI models. To date, preclinical studies strongly suggest that celastrol is highly effective in enhancing the cognitive performance of MI animal models, particularly in the memory domain, including spatial, recognition, retention and reference memories, via reduction in oxidative stress and attenuation of neuro-inflammation, among others. This review also emphasised the challenges and potential associated enhancement of medication delivery for MI treatment. Additionally, the potential structural alterations and derivatives of celastrol in enhancing its physicochemical and drug-likeness qualities are examined. The current review demonstrated that celastrol can improve cognitive performance and mitigate MI in several preclinical investigations, highlighting its potential as a natural lead molecule for the design and development of a novel neuroprotective medication. Graphical Abstract:

26 December 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
Siddharthan SelvarajSiddharthan Selvaraj
Siddharthan Selvaraj
Somasundaram PrasadhSomasundaram Prasadh
Somasundaram Prasadh
LWLing Shing Wong
Ling Shing Wong
SDSinouvassane Djearamane
Sinouvassane Djearamane
Vetriselvan SubramaniyanVetriselvan Subramaniyan
Vetriselvan Subramaniyan
NFNeeraj Fuloria
Neeraj Fuloria
SARS-CoV-2 is severe acute respiratory syndrome coronavirus 2 which induces severe pneumonia that has considerable death rate. In this article, we summarised the evolution of SARS CoV-2 from alpha to omicron variant. The origin, transmission capability, and innate immunity potential of the Omicron variety remain unknown in the aftermath of its appearance. It's also unclear whether further varieties based on Omicron may emerge in the future. However, there is no question that the Omicron version of SARS-CoV-2 would not be the last. The COVID-19 pandemic has become more difficult to control due to the constant appearance of new SARS-CoV-2 mutations. We have discussed about the epidemiology, treatment plans for SARS CoV-2 and preventive strategies for future pandemic.